Axogen (AXGN) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.50% |
| Dec 31, 2025 | 43.34% |
| Sep 30, 2025 | 12.98% |
| Jun 30, 2025 | 18.39% |
| Mar 31, 2025 | 39.23% |
| Dec 31, 2024 | 1.05% |
| Sep 30, 2024 | 15.88% |
| Jun 30, 2024 | 7.88% |
| Mar 31, 2024 | 11.10% |
| Dec 31, 2023 | -3.97% |
| Sep 30, 2023 | 16.51% |
| Jun 30, 2023 | 21.44% |
| Mar 31, 2023 | 11.31% |
| Dec 31, 2022 | 30.23% |
| Sep 30, 2022 | 33.17% |
| Jun 30, 2022 | 46.65% |
| Mar 31, 2022 | 25.84% |
| Dec 31, 2021 | 34.44% |
| Sep 30, 2021 | 58.22% |
| Jun 30, 2021 | 46.19% |
| Mar 31, 2021 | 71.24% |
| Dec 31, 2020 | 57.27% |
| Sep 30, 2020 | 54.52% |
| Jun 30, 2020 | 46.58% |
| Mar 31, 2020 | 8.59% |
| Dec 31, 2019 | 62.87% |
| Sep 30, 2019 | 60.12% |
| Jun 30, 2019 | 65.31% |
| Mar 31, 2019 | 107.54% |
| Dec 31, 2018 | 63.94% |
| Sep 30, 2018 | 73.12% |
| Jun 30, 2018 | 72.78% |
| Mar 31, 2018 | 46.08% |
| Dec 31, 2017 | 34.64% |
| Sep 30, 2017 | 39.98% |
| Jun 30, 2017 | 37.03% |
| Mar 31, 2017 | 39.99% |
| Dec 31, 2016 | 17.64% |
| Sep 30, 2016 | 50.92% |
| Jun 30, 2016 | 80.19% |
| Mar 31, 2016 | 43.56% |
| Dec 31, 2015 | 96.19% |
| Sep 30, 2015 | 14.26% |